NewsDialy
Anthropic has launched Claude Science, a new artificial intelligence product targeting the pharmaceutical industry, with stated applications in rendering three-dimensional protein structures and drug discovery.
The move signals a deliberate push by the AI company into life sciences as a revenue channel.
What Claude Science Does Claude Science is positioned as a specialist tool for scientific workflows, with use cases centred on two technically demanding tasks: visualising 3D protein structures and supporting the drug discovery process.
Protein structure rendering sits at the core of modern computational biology — understanding how a protein folds determines how it functions and, critically, where a drug molecule might bind to it.
Keep reading